Insmed | INSM - Текущие активы





Текущие активы Изменить Дата
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
DBV Technologies USD 212.94M 124.06M 2025-12
Gilead Sciences USD 19.89B 1.05B 2025-12
Heron Therapeutics USD 238.07M 8.67M 2025-12
Insmed USD 1.79B 137.6M 2025-12
Novartis USD 30.46B 2.26B 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Ultragenyx Pharmaceutical USD 951M 307.79M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03